Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay.
Danh K, Karp DG, Robinson PV, Seftel D, Stone M, Simmons G, Bagri A, Schreiber M, Buser A, Holbro A, Battegay M, Corash LM, Hanson C, Tsai CT. Danh K, et al. Among authors: stone m. medRxiv [Preprint]. 2020 Jun 2:2020.05.28.20105692. doi: 10.1101/2020.05.28.20105692. medRxiv. 2020. Update in: Nat Commun. 2022 Jul 21;13(1):4212. doi: 10.1038/s41467-022-31796-1 PMID: 32577696 Free PMC article. Updated. Preprint.
Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray.
de Assis RR, Jain A, Nakajima R, Jasinskas A, Felgner J, Obiero JM, Adenaiye O, Tai S, Hong F, Norris PJ, Stone M, Simmons G, Bagri A, Schreiber M, Buser A, Holbro A, Battegay M, Hosimer P, Noesen C, Milton DK; Prometheus Study Group; Davies DH, Contestable P, Corash LM, Busch MP, Felgner PL, Khan S. de Assis RR, et al. Among authors: stone m. bioRxiv [Preprint]. 2020 May 8:2020.04.15.043364. doi: 10.1101/2020.04.15.043364. bioRxiv. 2020. Update in: Nat Commun. 2021 Jan 4;12(1):6. doi: 10.1038/s41467-020-20095-2 PMID: 32511302 Free PMC article. Updated. Preprint.
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area.
Ng DL, Goldgof GM, Shy BR, Levine AG, Balcerek J, Bapat SP, Prostko J, Rodgers M, Coller K, Pearce S, Franz S, Du L, Stone M, Pillai SK, Sotomayor-Gonzalez A, Servellita V, Martin CSS, Granados A, Glasner DR, Han LM, Truong K, Akagi N, Nguyen DN, Neumann NM, Qazi D, Hsu E, Gu W, Santos YA, Custer B, Green V, Williamson P, Hills NK, Lu CM, Whitman JD, Stramer S, Wang C, Reyes K, Hakim JMC, Sujishi K, Alazzeh F, Pham L, Oon CY, Miller S, Kurtz T, Hackett J Jr, Simmons G, Busch MP, Chiu CY. Ng DL, et al. Among authors: stone m. medRxiv [Preprint]. 2020 May 25:2020.05.19.20107482. doi: 10.1101/2020.05.19.20107482. medRxiv. 2020. Update in: Nat Commun. 2020 Sep 17;11(1):4698. doi: 10.1038/s41467-020-18468-8 PMID: 32511477 Free PMC article. Updated. Preprint.
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.
Ng DL, Goldgof GM, Shy BR, Levine AG, Balcerek J, Bapat SP, Prostko J, Rodgers M, Coller K, Pearce S, Franz S, Du L, Stone M, Pillai SK, Sotomayor-Gonzalez A, Servellita V, Martin CSS, Granados A, Glasner DR, Han LM, Truong K, Akagi N, Nguyen DN, Neumann NM, Qazi D, Hsu E, Gu W, Santos YA, Custer B, Green V, Williamson P, Hills NK, Lu CM, Whitman JD, Stramer SL, Wang C, Reyes K, Hakim JMC, Sujishi K, Alazzeh F, Pham L, Thornborrow E, Oon CY, Miller S, Kurtz T, Simmons G, Hackett J Jr, Busch MP, Chiu CY. Ng DL, et al. Among authors: stone m. Nat Commun. 2020 Sep 17;11(1):4698. doi: 10.1038/s41467-020-18468-8. Nat Commun. 2020. PMID: 32943630 Free PMC article.
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.
de Assis RR, Jain A, Nakajima R, Jasinskas A, Felgner J, Obiero JM, Norris PJ, Stone M, Simmons G, Bagri A, Irsch J, Schreiber M, Buser A, Holbro A, Battegay M, Hosimer P, Noesen C, Adenaiye O, Tai S, Hong F, Milton DK, Davies DH, Contestable P, Corash LM, Busch MP, Felgner PL, Khan S. de Assis RR, et al. Among authors: stone m. Nat Commun. 2021 Jan 4;12(1):6. doi: 10.1038/s41467-020-20095-2. Nat Commun. 2021. PMID: 33397903 Free PMC article.
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay.
Goodhue Meyer E, Simmons G, Grebe E, Gannett M, Franz S, Darst O, Di Germanio C, Stone M, Contestable P, Prichard A, Reik R, Vassallo R, Young P, Busch MP, Williamson P, Dumont LJ. Goodhue Meyer E, et al. Among authors: stone m. Transfusion. 2021 Apr;61(4):1160-1170. doi: 10.1111/trf.16321. Epub 2021 Feb 18. Transfusion. 2021. PMID: 33554362 Free PMC article.
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammation.
Van Rompay KKA, Olstad KJ, Sammak RL, Dutra J, Watanabe JK, Usachenko JL, Immareddy R, Roh JW, Verma A, Shaan Lakshmanappa Y, Schmidt BA, Di Germanio C, Rizvi N, Stone M, Simmons G, Dumont LJ, Allen AM, Lockwood S, Pollard RE, de Assis RR, Yee JL, Nham PB, Ardeshir A, Deere JD, Patterson J, Jain A, Felgner PL, Iyer SS, Hartigan-O'Connor DJ, Busch MP, Reader JR. Van Rompay KKA, et al. Among authors: stone m. bioRxiv [Preprint]. 2021 Sep 1:2021.09.01.458520. doi: 10.1101/2021.09.01.458520. bioRxiv. 2021. Update in: PLoS Pathog. 2022 Apr 20;18(4):e1009925. doi: 10.1371/journal.ppat.1009925 PMID: 34494025 Free PMC article. Updated. Preprint.
Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.
Bagri A, de Assis RR, Tsai CT, Simmons G, Mei ZW, Von Goetz M, Gatmaitan M, Stone M, Di Germanio C, Martinelli R, Darst O, Rioveros J, Robinson PV, Ward D, Ziman A, Seftel D, Khan S, Busch MP, Felgner PL, Corash LM. Bagri A, et al. Among authors: stone m. Transfusion. 2022 Mar;62(3):570-583. doi: 10.1111/trf.16819. Epub 2022 Feb 12. Transfusion. 2022. PMID: 35128658 Free PMC article.
3,179 results